Used in pharmaceutical research as a key intermediate in the synthesis of selective kinase inhibitors, particularly those targeting tyrosine kinases involved in cancer cell proliferation. Its structure supports binding to ATP sites in kinases, making it valuable in developing anticancer agents. Also investigated for use in neurodegenerative disease treatments due to its ability to cross the blood-brain barrier and modulate neuronal signaling pathways. Employed in medicinal chemistry for structure-activity relationship (SAR) studies to optimize drug candidates for improved potency and selectivity.